Answers are grounded in this paper and cite their sources.
There have been fundamental changes in the approach to breast cancer management over the last century but the primary objective of achieving oncological safety remains unchanged. This evolution is highlighted with a summary of the key evidences in support of the oncological safety of breast conserving surgery (BCS) in early breast cancer (EBC) management. We will also discuss the increasingly pivotal role that neoadjuvant chemotherapy (NACT) may play, in the local treatment of EBC and locally advanced breast cancer (LABC) and the long-term surgical and oncological outcomes.
No takes yet. Share an insight, caveat, or question.
Murugappan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: